+499.5%
MRNA vs FGI
+81.8%
+417.6%
-34.2%
Performance
Returns, benchmark comparison, and relative performance.
Performance by timeframe
Returns for 1y.
| Period | Portfolio | FGI | Excess | Alpha |
|---|---|---|---|---|
| 1D | -2.2% | +7.5% | -9.8% | -2.2% |
| 7D | +5.5% | +0.5% | +4.9% | +5.5% |
| 30D | +158.7% | +65.4% | +93.3% | +155.2% |
| 3M | +182.1% | +23.5% | +158.6% | +179.5% |
| 6M | +151.8% | +60.5% | +91.3% | +143.9% |
| YTD | +393.6% | +30.0% | +363.6% | +381.2% |
| 1Y | +499.5% | +82.1% | +417.4% | +472.2% |
| All | +499.5% | +81.8% | +417.6% | +472.2% |
Cumulative growth
Daily Returns
Daily percentage return beside FGI.
Daily Out/Under-Performance
Portfolio return minus FGI return. Positive bars indicate outperformance.
Daily Alpha
Portfolio daily return minus β × FGI return. Early observations use the first valid beta; later observations use the trailing beta estimated for each date.
Cumulative Out/Under-Performance
Relative wealth over 1y: compounded portfolio wealth divided by compounded FGI wealth, less one. Both series rebase at the selected span's start.
Cumulative Alpha
Compounded beta-adjusted residual returns apply the first valid beta to early observations, then the trailing beta ending on each date.
Updating return analytics…
1y analysis · Full analysis span regression · 6 months rolling